| BRCA mutations in ovarian and prostate cancer: bench to bedside S Boussios, E Rassy, M Moschetta, A Ghose, S Adeleke, E Sanchez, ... Cancers 14 (16), 3888, 2022 | 98 | 2022 |
| Molecular targeted agents for gastric cancer: a step forward towards personalized therapy EU Cidon, SG Ellis, Y Inam, S Adeleke, S Zarif, T Geldart Cancers 5 (1), 64-91, 2013 | 69 | 2013 |
| First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma M Tran, A Latifoltojar, JB Neves, MV Papoutsaki, F Gong, A Comment, ... BJR| case reports 5 (3), 20190003, 2019 | 57 | 2019 |
| A framework for advancing sustainable magnetic resonance imaging access in Africa UC Anazodo, JJ Ng, B Ehiogu, J Obungoloch, A Fatade, HJMM Mutsaerts, ... NMR in Biomedicine 36 (3), e4846, 2023 | 54 | 2023 |
| Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls S Adeleke, A Haslam, A Choy, S Diaz-Cano, JR Galante, C Mikropoulos, ... Personalized medicine 19 (4), 277-286, 2022 | 48 | 2022 |
| Sustainable low-field cardiovascular magnetic resonance in changing healthcare systems C Qin, S Murali, E Lee, V Supramaniam, DJ Hausenloy, J Obungoloch, ... European Heart Journal-Cardiovascular Imaging 23 (6), e246-e260, 2022 | 30 | 2022 |
| Considerations for environmental sustainability in clinical radiology and radiotherapy practice: a systematic literature review and recommendations for a greener practice MNK Anudjo, C Vitale, W Elshami, A Hancock, S Adeleke, JM Franklin, ... Radiography 29 (6), 1077-1092, 2023 | 28 | 2023 |
| Challenges in glucoCEST MR body imaging at 3 Tesla M Kim, F Torrealdea, S Adeleke, M Rega, V Evans, T Beeston, K Soteriou, ... Quantitative imaging in medicine and surgery 9 (10), 1628, 2019 | 28 | 2019 |
| Bringing MRI to low‐and middle‐income countries: directions, challenges and potential solutions S Murali, H Ding, F Adedeji, C Qin, J Obungoloch, I Asllani, U Anazodo, ... NMR in Biomedicine 37 (7), e4992, 2024 | 27 | 2024 |
| The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer Y Wang, JR Galante, A Haroon, S Wan, A Afaq, H Payne, J Bomanji, ... Nature Reviews Urology 19 (8), 475-493, 2022 | 25 | 2022 |
| Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4 A Ghose, L McCann, S Makker, U Mukherjee, SVN Gullapalli, J Erekkath, ... Therapeutic advances in medical oncology 16, 17588359241233225, 2024 | 22 | 2024 |
| Magnetic resonance imaging and targeted biopsies compared to transperineal mapping biopsies before focal ablation in localised and metastatic recurrent prostate cancer after … TT Shah, A Kanthabalan, M Otieno, M Pavlou, R Omar, S Adeleke, ... European urology 81 (6), 598-605, 2022 | 16 | 2022 |
| Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole … S Adeleke, A Latifoltojar, H Sidhu, M Galazi, TT Shah, J Clemente, ... BMC medical imaging 19, 1-11, 2019 | 14 | 2019 |
| Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities CA Linares, A Varghese, A Ghose, SD Shinde, S Adeleke, E Sanchez, ... International Journal of Molecular Sciences 24 (17), 13215, 2023 | 13 | 2023 |
| A Phase I dose-escalation study of ATR inhibitor monotherapy with AZD6738 in advanced solid tumors (PATRIOT Part A) MT Dillon, A Espinasse, S Ellis, K Mohammed, LG Grove, L McLellan, ... Cancer research 77, 2017 | 13 | 2017 |
| Melanoma—the therapeutic considerations in the clinical practice S Adeleke, S Okoli, A Augustine, J Galante, A Agnihotri, M Uccello, ... Annals of Palliative Medicine 12 (6), 1355372-1351372, 2023 | 12 | 2023 |
| The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial A Light, A Kanthabalan, M Otieno, M Pavlou, R Omar, S Adeleke, ... European Urology 85 (1), 35-46, 2024 | 11 | 2024 |
| Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer P Parent, G Marcq, S Adeleke, A Turpin, S Boussios, E Rassy, N Penel Therapeutic Advances in Medical Oncology 15, 17588359231192402, 2023 | 10 | 2023 |
| Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly A Retter, F Gong, T Syer, S Singh, S Adeleke, S Punwani Molecular Oncology 15 (10), 2565-2579, 2021 | 10 | 2021 |
| Current applications and future development of magnetic resonance fingerprinting in diagnosis, characterization, and response monitoring in cancer H Ding, C Velasco, H Ye, T Lindner, M Grech-Sollars, J O’Callaghan, ... Cancers 13 (19), 4742, 2021 | 8 | 2021 |
Shonit PunwaniProfessor of Magnetic Resonance and Cancer Imaging, University College LondonEmail verificata su ucl.ac.uk